ClinicalTrials.gg

Program

Tetanus Toxoid

Also written as “Tetanus Toxoid (Adsorbed)” and “Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine”.

Its studies are mostly in Tetanus, led by 3 companies.

Furthest: phase 4, since Jul 28, 20263 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Beijing Minhai Biotechnology10 open or runningphase 3since Jul 28, 2026Jul 28, 2026none ahead
Sanofi10 open or runningphase 4since Sep 20, 2011Sep 20, 2011none ahead
Sinovac Biotech10 open or runningphase 2since Apr 15, 2025Apr 15, 2025none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 20, 2011First study: phase 4 study in TetanusNew to SanofiSanofi · NCT01439165 · 1,330 enrolled · United States, Canada
  2. Apr 15, 2025Sinovac Biotech's first study: phase 2 study in TetanusNew to Sinovac BiotechSinovac Biotech · NCT06939777 · 255 enrolled · China
  3. Jul 28, 2026Beijing Minhai Biotechnology's first study: phase 3 study in TetanusNew to Beijing Minhai BiotechnologyBeijing Minhai Biotechnology · NCT07740733 · 1,240 enrolled · China

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

“Tetanus toxoid vaccine antigen”ChEMBL 37, by rule

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07740733Tetanus · China3CompletedBeijing Minhai BiotechnologyDec 23, 20241,240
NCT06939777Tetanus · China2CompletedSinovac BiotechDec 8, 2025255
NCT01439165Tetanus · United States, Canada4CompletedSanofiDec 20151,330

How it is read

Names in the registry

  • “Tetanus Toxoid (Adsorbed)”, 2 entries
  • “Tetanus Toxoid”, 1 entry
  • “Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.